Menu Close

Hepatitis C Virus Antibody Screening in a Cohort of Pregnant Women: Identifying Seroprevalence and Risk Factors

Citation

Prasad, Mona; Saade, George R.; Sandoval, Grecio; Hughes, Brenna L.; Reddy, Uma M.; Mele, Lisa; Salazar, Ashley; Varner, Michael W.; Gyamfi-Bannerman, Cynthia; & Thorp, John M., Jr., et al. (2020). Hepatitis C Virus Antibody Screening in a Cohort of Pregnant Women: Identifying Seroprevalence and Risk Factors. Obstetrics and Gynecology, 135(4), 778-88.

Abstract

OBJECTIVE: To describe the prevalence of hepatitis C virus (HCV) antibody, evaluate current risk factors associated with HCV antibody positivity, and identify novel composite risk factors for identification of groups most likely to demonstrate HCV antibody seropositivity in an obstetric population from 2012 to 2015.

URL

http://dx.doi.org/10.1097/aog.0000000000003754

Reference Type

Journal Article

Journal Title

Obstetrics and Gynecology

Author(s)

Prasad, Mona
Saade, George R.
Sandoval, Grecio
Hughes, Brenna L.
Reddy, Uma M.
Mele, Lisa
Salazar, Ashley
Varner, Michael W.
Gyamfi-Bannerman, Cynthia
Thorp, John M., Jr.
Tita, Alan T. N.
Swamy, Geeta K.
Chien, Edward K.
Casey, Brian M.
Peaceman, Alan M.
El-Sayed, Yasser Y.
Iams, Jay D.
Gibbs, Ronald S.
Sibai, Baha
Wiese, Nicholas
Kamili, Saleem
Macones, George A., for the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network

Year Published

2020

Volume Number

135

Issue Number

4

Pages

778-88

Reference ID

12677